Endocyte, Inc. Press Releases

ECYT 
$18.15
*  
0.50
 negative 
2.68%
Get ECYT Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Endocyte Announces Presentations at AACR Annual Meeting 2014
4/4/2014 8:01:00 AM - GlobeNewswire

Endocyte, Inc. Closes Public Offering of Common Stock
4/2/2014 4:01:00 PM - GlobeNewswire

Endocyte, Inc. Prices Public Offering of Common Stock
3/27/2014 6:48:00 PM - GlobeNewswire

Healthcare Companies Report Clinical Study Results, Financial Results and Stock Summaries - Analyst Notes on Endocyte, Ophthotech, AcelRx Pharmaceuticals, bluebird bio, and Cantel Medical
3/26/2014 8:00:00 AM - PR Newswire

Endocyte, Inc. Announces Proposed Offering of Common Stock
3/25/2014 4:32:00 PM - GlobeNewswire

Technical Pointers on Top Gainers -- Research on Newfield Exploration, Endocyte, Columbia Property Trust, and AVEO Pharma
3/24/2014 10:09:00 AM - PR Newswire

Endocyte Announces Phase 2b TARGET Trial Results Evaluating Vintafolide/Docetaxel Combination in Non-Small Cell Lung Cancer (NSCLC) Met the Primary Endpoint of Improved Progression Free Survival
3/21/2014 8:09:00 AM - GlobeNewswire

Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT® (vintafolide) and Companion Imaging Agents FOLCEPRI® (etarfolatide) and NEOCEPRI® (Intravenous (IV) folic acid) in Patients with Platinum-Resistant ...
3/21/2014 8:05:00 AM - Business Wire

Endocyte to Present at Upcoming Conferences in March
2/25/2014 4:01:00 PM - GlobeNewswire

Endocyte Reports Fourth Quarter and Year End 2013 Financial Results and Provides Business Update
2/24/2014 7:30:00 AM - GlobeNewswire

Endocyte Announces Fourth Quarter and Full Year 2013 Earnings Conference Call
2/17/2014 4:01:00 PM - GlobeNewswire

Endocyte to Present at Upcoming Conferences
2/6/2014 4:01:00 PM - GlobeNewswire

Endocyte Provides Update on CHMP Review of Pending EU Conditional Marketing Authorization Applications for Vintafolide and Etarfolatide
1/24/2014 7:27:00 AM - GlobeNewswire